Reostral

Reostral Brand names, Reostral Analogs

Reostral Brand Names Mixture

No information avaliable

Reostral Chemical_Formula

C₂₀H₂₃NS

Reostral RX_link

No information avaliable

Reostral fda sheet

Reostral msds (material safety sheet)

Reostral Synthesis Reference

No information avaliable

Reostral Molecular Weight

309.469 g/mol

Reostral Melting Point

< 25 ^oC

Reostral H₂O Solubility

Soluble as HCl salt

Reostral State

Liquid

Reostral LogP

5.7

Reostral Dosage Forms

Tablets (oral, 1 mg)

Reostral Indication

Used for the symptomatic treatment of parkinsonism.

Reostral Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Reostral Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Reostral side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Reostral Patient Information

Reostral Organisms Affected

Humans and other mammals